Equity Distribution Agreements in the Pharmaceuticals Industry

48 Contracts & Agreements
Browse by Company
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Tvardi Therapeutics, Inc. RSU Award Grant Notice and Agreement (2025 Equity Incentive Plan)
Equity Distribution Agreements
Cara Therapeutics, Inc.
Pharmaceuticals
2025
Tvardi Therapeutics, Inc. 2025 Equity Incentive Plan
Equity Distribution Agreements
Cara Therapeutics, Inc.
Pharmaceuticals
DE
2025
Description of Eyenovia, Inc. Common Stock and Warrants Registered Under Section 12 of the Exchange Act
Equity Distribution Agreements
EYENOVIA, INC.
Pharmaceuticals
2025
Placement Agency Agreement between CNS Pharmaceuticals, Inc. and A.G.P./Alliance Global Partners (April 2025)
Equity Distribution Agreements
CNS Pharmaceuticals, Inc.
Pharmaceuticals
NY
2025
Description of Registered Securities of TNF Pharmaceuticals, Inc. under Section 12 of the Exchange Act
Equity Distribution Agreements
Akers Biosciences, Inc.
Pharmaceuticals
2025
At the Market Offering Agreement between Lipella Pharmaceuticals Inc. and H.C. Wainwright & Co., LLC (April 4, 2025)
Equity Distribution Agreements
LIPELLA PHARMACEUTICALS INC
Pharmaceuticals
NY
2025
Description of Capital Stock and Anti-Takeover Provisions under Amended and Restated Certificate of Incorporation and Bylaws
Equity Distribution Agreements
NovaBay Pharmaceuticals, Inc.
Pharmaceuticals
2025
Equity Distribution Agreement, dated as of February 28, 2025, by and among Canopy Growth Corporation and BMO Capital Markets Corp. and BMO Nesbitt Burns Inc
Equity Distribution Agreements
Canopy Growth Corp
Pharmaceuticals
2025
Equity Distribution Agreement, dated as of July 12, 2024, by and between Zevra Therapeutics, Inc. and Citizens JMP Securities, LLC
Equity Distribution Agreements
KEMPHARM, INC
Pharmaceuticals
DE
2024
Equity Distribution Agreement, dated as of June 6, 2024, by and among Canopy Growth Corporation and BMO Capital Markets Corp. and BMO Nesbitt Burns Inc
Equity Distribution Agreements
Canopy Growth Corp
Pharmaceuticals
2024
Equity Distribution Agreement, dated as of May 17, 2024, by and among Tilray Brands, Inc. and TD Securities (USA) LLC and Jefferies LLC
Equity Distribution Agreements
Tilray, Inc.
Pharmaceuticals
NY
2024
Amendment No. 1 to Equity Distribution Agreement, by and between Sonoma Pharmaceuticals, Inc. and Maxim Group LLC., dated March 8, 2024
Equity Distribution Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2024
Equity Distribution Agreement, by and between Sonoma Pharmaceuticals, Inc. and Maxim Group LLC., dated December 15, 2023
Equity Distribution Agreements
Sonoma Pharmaceuticals, Inc.
Pharmaceuticals
NY
2023
Equity Distribution Agreement, dated as of October 2, 2023, by and between Biohaven Ltd. and J.P. Morgan Securities LLC
Equity Distribution Agreements
Biohaven Ltd.
Pharmaceuticals
NY
2023
Amendment No. 1 to the Equity Distribution Agreement, dated as of March 31, 2023, by and between Marinus Pharmaceuticals, Inc. and JMP Securities LLC
Equity Distribution Agreements
MARINUS PHARMACEUTICALS INC
Pharmaceuticals
2023
Equity distribution agreement, dated as of August 12, 2022
Equity Distribution Agreements
Lexaria Bioscience Corp.
Pharmaceuticals
NY
2022
Equity Distribution Agreement, dated May 9, 2022, by and between the Company and Piper Sandler & Co
Equity Distribution Agreements
Fulcrum Therapeutics, Inc.
Pharmaceuticals
NY
2022
Equity Distribution Agreement, dated
Equity Distribution Agreements
Novan, Inc.
Pharmaceuticals
NY
2022
Equity Distribution Agreement, dated January 14, 2022, by and between Clever Leaves Holdings Inc. and Canaccord Genuity LLC
Equity Distribution Agreements
Clever Leaves Holdings Inc.
Pharmaceuticals
NY
2022
Equity Distribution Agreement, dated September 1, 2021, by and between the Company and Cantor Fitzgerald & Co
Equity Distribution Agreements
ORAMED PHARMACEUTICALS INC.
Pharmaceuticals
NY
2021
Equity Distribution Agreement, dated August 20, 2021, by and among Processa Pharmaceuticals, Inc. and Oppenheimer & Co. Inc
Equity Distribution Agreements
Processa Pharmaceuticals, Inc.
Pharmaceuticals
NY
2021
Equity Distribution Agreement, dated as of August 20, 2021, between Onconova Therapeutics, Inc. and Piper Sandler & Co
Equity Distribution Agreements
Onconova Therapeutics, Inc.
Pharmaceuticals
NY
2021
Equity Distribution Agreement, dated August 6, 2021, by and among Arvinas, Inc., Piper Sandler & Co. and Cantor Fitzgerald & Co
Equity Distribution Agreements
ARVINAS, INC.
Pharmaceuticals
NY
2021
Equity Distribution Agreement, dated July 15, 2021, by and between the Company and Canaccord Genuity
Equity Distribution Agreements
ORAMED PHARMACEUTICALS INC.
Pharmaceuticals
NY
2021
Equity Distribution Agreement, dated July 2, 2021, by and among KemPharm, Inc., JMP Securities LLC and RBC Capital Markets, LLC
Equity Distribution Agreements
KEMPHARM, INC
Pharmaceuticals
DE
2021
Equity Distribution Agreement, dated June 16, 2021, by and between the Company and Canaccord Genuity
Equity Distribution Agreements
ORAMED PHARMACEUTICALS INC.
Pharmaceuticals
NY
2021
Letter amending the Standby Equity Distribution Agreement by and between the Institutional Investor and Acreage Holdings, Inc., dated March 11, 2021
Equity Distribution Agreements
Acreage Holdings, Inc.
Pharmaceuticals
2021
Amendment No. 1 to the Equity Distribution Agreement, dated March 26, 2021, by and between Aquestive Therapeutics, Inc. and Piper Sandler & Co
Equity Distribution Agreements
Aquestive Therapeutics, Inc.
Pharmaceuticals
NY
2021
Equity Distribution Agreement, dated December 1, 2020, by and between the Company and Canaccord Genuity
Equity Distribution Agreements
ORAMED PHARMACEUTICALS INC.
Pharmaceuticals
NY
2020
Equity Distribution Agreement by and among the Company and Maxim Group LLC dated as of April 13, 2020
Equity Distribution Agreements
ARTELO BIOSCIENCES, INC.
Pharmaceuticals
NY
2020
Amendment to the Equity Distribution Agreement, dated February 10, 2020, between Canaccord Genuity LLC and Oramed Pharmaceuticals Inc
Equity Distribution Agreements
ORAMED PHARMACEUTICALS INC.
Pharmaceuticals
2020
Equity Distribution Agreement, dated as of March 6, 2020, between VIVUS, Inc. and Piper Sandler & Co
Equity Distribution Agreements
VIVUS INC
Pharmaceuticals
NY
2020
Amendment to the Amended and Restated Equity Distribution Agreement, dated October 2, 2019
Equity Distribution Agreements
Cocrystal Pharma, Inc.
Pharmaceuticals
2020
Amended and Restated Equity Distribution Agreement, dated October 30, 2019
Equity Distribution Agreements
Cocrystal Pharma, Inc.
Pharmaceuticals
DE
2019
Equity Distribution Agreement, dated September 5, 2019, by and between the Company and Canaccord Genuity
Equity Distribution Agreements
ORAMED PHARMACEUTICALS INC.
Pharmaceuticals
NY
2019
Equity Distribution Agreement, dated as of June 17, 2019, by and between Seelos Therapeutics, Inc. and Piper Jaffray & Co
Equity Distribution Agreements
APRICUS BIOSCIENCES, INC.
Pharmaceuticals
NY
2019
Equity Distribution Agreement, dated as of April 12, 2019, by and between Canaccord Genuity LLC and Ampio Pharmaceuticals, Inc
Equity Distribution Agreements
Ampio Pharmaceuticals, Inc.
Pharmaceuticals
NY
2019
Amendment to Equity Distribution Agreement, dated March 20, 2019
Equity Distribution Agreements
Cocrystal Pharma, Inc.
Pharmaceuticals
2019
Equity Distribution Agreement, dated November 16, 2018, by and between Eloxx Pharmaceuticals, Inc., Citigroup Global Markets Inc. and Cantor Fitzgerald & Co
Equity Distribution Agreements
Eloxx Pharmaceuticals, Inc.
Pharmaceuticals
NY
2018
Equity Distribution Agreement, dated July 19, 2018
Equity Distribution Agreements
Cocrystal Pharma, Inc.
Pharmaceuticals
DE
2018